Innate immunity and cardiomyocytes in ischemic heart disease
about
Epicardial Fat: Physiological, Pathological, and Therapeutic ImplicationsIschemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptorCardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped NanosilverSystemic injection of low-dose lipopolysaccharide fails to break down the blood-brain barrier or activate the TLR4-MyD88 pathway in neonatal rat brain.Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction.Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes.Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injuryEffect of dexmedetomidine on myocardial ischemia-reperfusion injury.Role of inflammatory cells in fibroblast activation.Transcriptome profiling of 3D co-cultured cardiomyocytes and endothelial cells under oxidative stress using a photocrosslinkable hydrogel system.Myocardial ischemia/reperfusion injury: the role of adaptor proteins Crk.TLR3 contributes to persistent autophagy and heart failure in mice after myocardial infarction.Sulforaphane improves oxidative status without attenuating the inflammatory response or cardiac impairment induced by ischemia-reperfusion in rats.The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.Insights into innate immune signalling in controlling cardiac remodelling.MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-κB activation and suppressing inflammation-associated microRNA expression.Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure.Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis
P2860
Q26746996-4F3548B8-9A87-4EA6-8906-64D45D4C5AA3Q28082430-CBA48293-B8E1-49E1-848A-2980C92E3616Q29248143-7CE36CA8-B562-4026-A138-BB49DEF62DC0Q33907683-D2A552AE-7345-4E47-B2BC-EC767BDA0D52Q35750924-71C61075-D38C-44E1-8152-88AABD6C8A6CQ36013581-E3F9CE8A-068D-4F63-88A0-3765713969E6Q36142000-19C9F89D-C622-4416-8F76-1A62BDA37C68Q36205799-1D617260-BC8D-4B28-8C6F-B8D4FF13F37FQ36493011-2A8556BE-FFE5-421A-BF57-262036FBA290Q38643076-D27EFADF-2CBF-4585-A87C-A40EC52780E8Q38709842-065B64D8-E92A-484D-AF83-939D9D9394E2Q38758780-C316D5D6-0B49-4758-BB84-E93B3F139FDBQ41911901-F7C66B4D-3419-4B1C-98EF-AF69FDF298BFQ46592298-990275B3-0A82-4B77-BFB2-D0C3163CD2BFQ47553695-ADDFCFF3-C3A4-4369-9DD1-7959E1F65B2BQ49634849-91C466FC-E944-4407-A917-8CA4F452978AQ52448624-D5076E6C-5279-42D6-B72E-E79EF87851D6Q54168046-4B12B69C-7566-4CC9-B93A-9715EB5B99F2Q55363616-6E6F834B-A547-4736-9DDB-AE40A4AA3867Q58127453-86B31123-FC53-411D-A196-E12F13BF220E
P2860
Innate immunity and cardiomyocytes in ischemic heart disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Innate immunity and cardiomyocytes in ischemic heart disease
@ast
Innate immunity and cardiomyocytes in ischemic heart disease
@en
Innate immunity and cardiomyocytes in ischemic heart disease
@nl
type
label
Innate immunity and cardiomyocytes in ischemic heart disease
@ast
Innate immunity and cardiomyocytes in ischemic heart disease
@en
Innate immunity and cardiomyocytes in ischemic heart disease
@nl
prefLabel
Innate immunity and cardiomyocytes in ischemic heart disease
@ast
Innate immunity and cardiomyocytes in ischemic heart disease
@en
Innate immunity and cardiomyocytes in ischemic heart disease
@nl
P2860
P3181
P1433
P1476
Innate immunity and cardiomyocytes in ischemic heart disease
@en
P2093
Anne A. Knowlton
P2860
P3181
P356
10.1016/J.LFS.2014.01.062
P407
P577
2014-03-28T00:00:00Z